Cash Live
    Trending
    • Stocks making the biggest moves premarket: Foot Locker, Deere, DoorDash and others
    • Taylor Swift’s advice for young people: Hearing the word ‘no’ was ‘more crucial than the moments I was told yes’
    • Europe admits it’ll have to burn more coal as it tries to wean itself off Russian energy
    • Cisco stock plunges as company forecasts surprising revenue decline
    • You can’t put money in a health savings account once you’re on Medicare. A House bill to change that comes with tradeoffs
    • House Democrats push for state and local taxes relief in appropriations bill
    • Climbing interest rates mean good news for annuity buyers
    • Chinese electric car start-up Nio says supply chain disruption, not demand, is its biggest problem
    • Personal Finance
    • Investing
      • Investing
      • Advisors
      • Investor Tips
    • Earnings
    • Business
      • Business
      • Small Business
    • Finance
      • Finance
      • Wealth
    Cash Live
    Home»Earnings»Pfizer cuts 2022 earnings outlook despite strong first quarter Covid vaccine and antiviral sales
    Earnings

    Pfizer cuts 2022 earnings outlook despite strong first quarter Covid vaccine and antiviral sales

    May 3, 2022No Comments3 Mins Read
    105687507 1547831143627bourla
    Share
    Facebook Twitter LinkedIn Pinterest Email

    In this article

    • PFE
    Albert Bourla, chief executive officer of Pfizer pharmaceutical company, arrives to ring the closing bell at the New York Stock Exchange.
    Drew Angerer | Getty Images

    Pfizer beat on its top and bottom line in its first quarter earnings report after booking strong sales of its Covid vaccine and oral antiviral treatment.

    The pharmaceutical giant’s first quarter revenue grew 77% to more than $25 billion compared to the same period last year. Pfizer’s revenue growth was driven by $13.2 billion in Covid vaccine sales in the quarter and $1.5 billion in sales of its oral antiviral treatment Paxlovid.

    Pfizer booked a net income of $7.8 billion, a 61% increase over the first quarter of 2021. Adjusted earnings grew 72% to $1.62 per share compared to the same period last year.

    The company’s stock fell more than 1% in premarket trading.

    Here’s how Pfizer performed compared to what Wall Street expected for the first quarter, based on analysts’ average estimates compiled by Refinitiv:

    • Adjusted EPS: $1.62 per share, vs. $1.47 expected
    • Revenue: $25.66 billion, vs. $23.86 billion expected

    Pfizer said booster doses and shots for children drove its Covid vaccine revenue. Paxlovid sales were driven by the antiviral treatment’s launch U.S., which has ordered 20 million courses.

    Pfizer reaffirmed its full-year 2022 guidance of $32 billion in Covid vaccine sales and $22 billion for Paxlovid. CEO Albert Bourla had told analysts earlier this year that revenue from its antiviral treatment could come in higher because estimates are based only on deals signed or those close  to finalization. 

    The company is still projecting $98 billion to $102 billion in total sales for 2022.

    Paxlovid is an effective treatment for people who have Covid, but it does not prevent infection. Paxlovid reduced the risk of hospitalization or death from Covid by 90% in a clinical trial of adults who caught the virus and were at high risk of developing severe illness. However, it failed to prevent infection in separate trial results published Friday by Pfizer. 

    Pfizer is submitting data to the Food and Drug Administration on its three-dose vaccine for children under 5-years-old, the only age group left in the U.S. that is not yet eligible for a shot. Bourla, in a podcast interview, said he hopes the vaccine for kids will receive authorization in June. The FDA had originally sought to authorize the first two doses in February, but Pfizer postponed its application because the data wasn’t good enough. Bourla has said a third dose should significantly increase protection for the youngest children. 

    CNBC Health & Science

    Read CNBC’s latest global coverage of the Covid pandemic:

    • Philadelphia keeps indoor mask mandate in place despite Florida judge ruling against CDC
    • Moderna says redesigned Covid vaccine produced stronger immunity against omicron than current shots
    • J&J lowers 2022 revenue and earnings expectations, stops giving Covid vaccine sales guidance
    • William Husel, Ohio doctor accused in 14 high-dose fentanyl deaths, acquitted of murder
    • Where you still legally need to wear Covid face masks — and where you don’t anymore

    This is a developing story. Please check back for updates.

    This article was originally published by Cnbc.com. Read the original article here.
    “Managed
    fqw82np

      Related Posts

      Cisco stock plunges as company forecasts surprising revenue decline

      May 20, 2022

      Palo Alto Networks stock jumps after company lifts full-year forecast

      May 20, 2022

      Kohl’s says final sale bids expected in coming weeks; retailer slashes full-year outlook after earnings miss

      May 19, 2022

      Bath & Body Works shares fall as retailer cuts profit outlook due to inflation

      May 19, 2022
      Add A Comment

      Leave A Reply Cancel Reply

      Signup for our Newsletter
      Advert
      “Cryptocurrency
      Investing

      Crypto exchange FTX U.S. moves into stock trading

      May 19, 2022

      Rising fuel costs are a massive problem for business and consumers — Here’s why they’re so high

      May 19, 2022

      Melvin Capital says it’s winding down funds and returning money to investors during market turmoil

      May 19, 2022

      Robinhood shares jump 25% after crypto CEO Sam Bankman-Fried acquires stake

      May 18, 2022
      Finance

      Stocks making the biggest moves premarket: Foot Locker, Deere, DoorDash and others

      May 20, 2022

      You can’t put money in a health savings account once you’re on Medicare. A House bill to change that comes with tradeoffs

      May 20, 2022

      Climbing interest rates mean good news for annuity buyers

      May 20, 2022

      Chinese electric car start-up Nio says supply chain disruption, not demand, is its biggest problem

      May 20, 2022
      Earnings

      Cisco stock plunges as company forecasts surprising revenue decline

      May 20, 2022

      Palo Alto Networks stock jumps after company lifts full-year forecast

      May 20, 2022

      Kohl’s says final sale bids expected in coming weeks; retailer slashes full-year outlook after earnings miss

      May 19, 2022

      Bath & Body Works shares fall as retailer cuts profit outlook due to inflation

      May 19, 2022
      Categories
      • Advisors
      • Business
      • Earnings
      • Finance
      • Investing
      • Investor Tips
      • Personal finance
      • Small Business
      • Wealth
      Archives
      • May 2022
      • April 2022
      • March 2022
      • February 2022
      • January 2022
      • December 2021
      • November 2021
      • October 2021
      • September 2021
      • August 2021
      • July 2021
      • June 2021
      • May 2021
      • April 2021
      • March 2021
      • February 2021
      • January 2021
      • December 2020
      • November 2020
      • October 2020
      • September 2020
      • August 2020
      • July 2020
      • June 2020
      • May 2020
      • April 2020
      • March 2020
      • February 2020
      • January 2020
      • September 2019
      • July 2019
      • September 2018
      • May 2018
      • March 2018
      • February 2018
      • December 2017
      • September 2017
      • June 2017
      • May 2017
      • April 2017
      • March 2017
      • December 2016
      • September 2016
      • August 2016
      • July 2016
      • June 2016
      • May 2016
      • April 2016
      • March 2016
      • October 2015
      • September 2015
      • July 2015
      • June 2015
      • March 2015
      • February 2015
      • January 2015
      • December 2014
      • October 2014
      • September 2014
      • July 2014
      Signup for our Newsletter
      Advert
      “Cryptocurrency
      Uselful links
      • Contact
      • About us
      • DMCA / Copyrights Disclaimer
      • Privacy Policy
      • Terms and Conditions
      • Cookie Policy (US)
      • Cookie Policy (EU)
      © 2022 Designed and Powered by JL Digital webbyrå.

      Type above and press Enter to search. Press Esc to cancel.

      Manage Cookie Consent
      To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
      Functional Always active
      The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
      Preferences
      The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
      Statistics
      The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
      Marketing
      The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
      Manage options Manage services Manage vendors Read more about these purposes
      View preferences
      {title} {title} {title}